id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-D-0436-0029,FDA,FDA-2011-D-0436,01 Final Guidance for Industry Q11 Development and Manufacture of Drug Substances--Questions and Answers (Chemical Entities and BiotechnologicalBiological Entities),Other,Guidance,2018-02-26T05:00:00Z,2018,2,2018-02-26T05:00:00Z,,2024-11-07T01:22:26Z,,1,0,0900006482f632d2
FDA-2011-D-0436-0028,FDA,FDA-2011-D-0436,"Q11 Development and Manufacture of Drug Substances—Questions and
Answers (Chemical Entities and Biotechnological/Biological Entities);
International Council for Harmonisation; Guidance for Industry;  Availability",Notice,Notice of Availability,2018-02-26T05:00:00Z,2018,2,2018-02-26T05:00:00Z,,2018-02-26T16:48:04Z,2018-03809,0,0,0900006482f61eec